Correction to: Scientific Reports https://doi.org/10.1038/s41598-017-13305-3, published online 30 October 2017
This Article contains an error in Figure 1C, where the representative blot for NLRP3 is incorrect.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sun, NN., Yu, C.H., Pan, MX. et al. Author Correction: Mir-21 Mediates the Inhibitory Effect of Ang (1–7) on AngII-induced NLRP3 Inflammasome Activation by Targeting Spry1 in lung fibroblasts. Sci Rep 10, 21896 (2020). https://doi.org/10.1038/s41598-020-78308-z
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-020-78308-z
This article is cited by
-
ACE2, a therapeutic target of COVID-19, needs to be treated with caution
Archives of Virology (2025)
